Literature DB >> 15585629

Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.

Katsuhiko Nosho1, Hiroyuki Yamamoto, Hiroaki Taniguchi, Yasushi Adachi, Yukinari Yoshida, Yoshiaki Arimura, Takao Endo, Yuji Hinoda, Kohzoh Imai.   

Abstract

PURPOSE: The aim of this study was to characterize the relationship of insulin-like growth factor (IGF)-II expression with IGF-I, IGF-I receptor (IGF-IR), cyclooxygenase-2 (COX-2), and matrix metalloproteinase (MMP)-7 in early colorectal carcinogenesis. EXPERIMENTAL
DESIGN: With the semiquantitative reverse transcriptase-PCR, 90 human colorectal tumor tissues (63 adenomas and 27 submucosal pT1 cancers) were analyzed for IGF-II, IGF-IR, IGF-I, COX-2, and MMP-7 expression. Ninety-nine adenoma tissues and 60 pT1 cancer tissues were also analyzed immunohistochemically for IGF-II expression. Loss of imprinting of the IGF-II gene was analyzed. Paired carcinoma and adenoma tissues obtained from a carcinoma in adenoma lesion was analyzed by a cDNA array.
RESULTS: IGF-II mRNA expression was detected in 37.8% of the 90 colorectal tumor tissues. The frequency of IGF-II mRNA expression was significantly higher in pT1 cancer (70.4%) than in adenoma (23.8%). Immunohistochemical IGF-II expression was also more frequently detected in pT1 cancer (58.3%) than in adenoma (25.3%). Loss of imprinting of the IGF-II gene was observed in 15 (44.1%) of the 34 colorectal tumors in which IGF-II was overexpressed. IGF-II expression was positively correlated with the expression of IGF-IR and IGF-I. COX-2 and MMP-7 mRNA expression was detected in 42.2% and 77.8% of the tumor tissues, respectively, and both were positively correlated with IGF-I, IGF-II, and IGF-IR expression. IGF-II was the most differentially expressed gene between carcinoma and adenoma lesions.
CONCLUSIONS: IGF-II, in conjunction with IGF-IR, IGF-I, COX-2, and MMP-7, seems to play a key role in the early stage of colorectal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15585629     DOI: 10.1158/1078-0432.CCR-04-0875

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  20 in total

Review 1.  Insulin-like growth factors in the gastrointestinal tract and liver.

Authors:  John F Kuemmerle
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-15       Impact factor: 4.741

2.  Laterally spreading tumour in which interstitial deletion of beta-catenin exon 3 was detected.

Authors:  K Nosho; H Yamamoto; M Mikami; T Takahashi; Y Adachi; T Endo; K Hirata; K Imai; Y Shinomura
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

Review 3.  Role of insulin-like growth factor-1R system in colorectal carcinogenesis.

Authors:  Erin A Donovan; Shivaani Kummar
Journal:  Crit Rev Oncol Hematol       Date:  2007-10-31       Impact factor: 6.312

4.  Current status of gene expression profiling to assist decision making in stage II colon cancer.

Authors:  Cheng E Chee; Neal J Meropol
Journal:  Oncologist       Date:  2014-05-28

5.  Clinicopathological significance and impact on outcomes of the gene expression levels of IGF-1, IGF-2 and IGF-1R, IGFBP-3 in patients with colorectal cancer: Overexpression of the IGFBP-3 gene is an effective predictor of outcomes in patients with colorectal cancer.

Authors:  Naoto Yamamoto; Takashi Oshima; Kazue Yoshihara; Toru Aoyama; Tsutomu Hayashi; Takanobu Yamada; Tsutomu Sato; Manabu Shiozawa; Takaki Yoshikawa; Soichiro Morinaga; Yasushi Rino; Chikara Kunisaki; Katsuaki Tanaka; Makoto Akaike; Toshio Imada; Munetaka Masuda
Journal:  Oncol Lett       Date:  2017-03-28       Impact factor: 2.967

6.  A candidate targeting molecule of insulin-like growth factor-I receptor for gastrointestinal cancers.

Authors:  Yasushi Adachi; Hiroyuki Yamamoto; Hirokazu Ohashi; Takao Endo; David-P Carbone; Kohzoh Imai; Yasuhisa Shinomura
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

7.  Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.

Authors:  Martha L Slattery; Roger K Wolff; Karen Curtin; Frank Fitzpatrick; Jennifer Herrick; John D Potter; Bette J Caan; Wade S Samowitz
Journal:  Mutat Res       Date:  2008-10-15       Impact factor: 2.433

8.  IGF-IR in patients with advanced colorectal cancer in correlation with certain clinico-morphological factors: Initial report.

Authors:  Adam Kuklinski; Zbigniew Kamocki; Mariusz Koda; Zdzislaw Piotrowski; Stanislaw Sulkowski; Ryszard Lesniewicz; Krystyna Pawlak; Piotr Mysliwiec; Boguslaw Kedra
Journal:  Oncol Lett       Date:  2011-08-29       Impact factor: 2.967

9.  Progastrin-induced secretion of insulin-like growth factor 2 from colonic myofibroblasts stimulates colonic epithelial proliferation in mice.

Authors:  Carrie A Duckworth; Daniel Clyde; Daniel L Worthley; Timothy C Wang; Andrea Varro; D Mark Pritchard
Journal:  Gastroenterology       Date:  2013-03-19       Impact factor: 22.682

10.  Gene Signatures in Stage II Colon Cancer: A Clinical Review.

Authors:  Saima Sharif; Michael J O'Connell
Journal:  Curr Colorectal Cancer Rep       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.